Literature DB >> 33853717

Etiology-, Sex-, and Tumor Size-Based Differences in Adrenocorticotropin-Dependent Cushing Syndrome.

Rama Walia1, Aditya Dutta2, Nidhi Gupta2, Anil Bhansali2, Rosario Pivonello3, Chirag Kamal Ahuja4, Sivashanmugam Dhandapani5, Pinaki Dutta2, Sanjay Kumar Bhadada2, Chiara Simeoli3, Abhishek Hajela2, Naresh Sachdeva2, Uma Nahar Saikia6.   

Abstract

OBJECTIVE: To examine demographic, clinical, and biochemical differences in patients with adrenocorticotropin (ACTH)-dependent Cushing syndrome (CS) based on etiology, sex, and tumor size.
METHODS: This was a single-center study of 211 patients with ACTH-dependent CS followed for 35 years. Patients were stratified into 3 groups based on etiology: Cushing disease (CD)/transsphenoidal surgery, Cushing disease/total bilateral adrenalectomy (CD/TBA), and ectopic ACTH secretion (EAS). Patients were also stratified based on sex and tumor size (nonvisualized, microadenoma, and macroadenoma).
RESULTS: CD was the commonest cause of ACTH-dependent CS (190; 90%). Most patients presented in the third decade (median age, 29 years). Clinical features, cortisol, and ACTH were significantly greater in the EAS group. The CD/TBA group had more nonvisualized tumors (22% vs 8%; P = .000) and smaller tumor size (4 vs 6 mm; P = .001) compared with the CD/transsphenoidal surgery group. There was female predominance in CD (2.06:1) and male predominance in EAS (2:1). Men had shorter duration of symptoms (2 years; P = .014), were younger (23 years; P = .001), had lower body mass index (25.1 kg/m2; P = .000), and had more severe disease (low bone mineral density, hypokalemia). Macroadenomas were frequent (46; 24.2%), and ACTH correlated with tumor size in CD (r = 0.226; P = .005).
CONCLUSION: Our cohort presented at an earlier age than the Western population with a distinct, but slightly lower, female predilection. Patients with CD undergoing TBA had frequent negative imaging. Men had a clinical profile suggesting aggressive disease. Microadenoma and macroadenoma were difficult to distinguish on a clinicobiochemical basis.
Copyright © 2020 AACE. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ACTH-dependent Cushing syndrome; Cushing disease; sex; tumor size

Mesh:

Substances:

Year:  2020        PMID: 33853717     DOI: 10.1016/j.eprac.2020.11.014

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  1 in total

1.  Clinical Study and Systematic Review of Pituitary Microadenomas vs. Macroadenomas in Cushing's Disease: Does Size Matter?

Authors:  Amit Akirov; Ilan Shimon; Maria Fleseriu; Idit Dotan; Yossi Manisterski; Nirit Aviran-Barak; Varda Nadler; Sandra Alboim; Tzipora Shochat; Gloria Tsvetov; Dania Hirsch
Journal:  J Clin Med       Date:  2022-03-11       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.